No title
Objectives Investigating men's perceived lifetime risk of prostate cancer. Design Survey-based study to men invited for prostate-specific antigen (PSA) screening in the GÖTEBORG-2 trial between September 2015 and June 2020. Setting 38 775 men in the Gothenburg area, Sweden, were invited for PSA-Testing and participated in a survey. Participants 17 980 men participated in PSA-Testing, of whom 13 18
